Julio Bobes
Overview
Explore the profile of Julio Bobes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
335
Citations
6739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferraro L, Di Forti M, La Barbera D, La Cascia C, Morgan C, Tripoli G, et al.
Psychol Med
. 2025 Feb;
55:e12.
PMID: 39905765
Background: Previous studies identified clusters of first-episode psychosis (FEP) patients based on cognition and premorbid adjustment. This study examined a range of socio-environmental risk factors associated with clusters of FEP,...
2.
Bond B, Duric B, Spinazzola E, Trotta G, Chesney E, Li Z, et al.
Can J Psychiatry
. 2025 Jan;
70(3):182-193.
PMID: 39810593
Objectives: To establish whether the risk of psychotic disorders in cannabis users changes with time following cannabis cessation using data from the European Network of National Networks studying Gene-Environment Interactions...
3.
Rodriguez V, Alameda L, Aas M, Gayer-Anderson C, Trotta G, Spinazzola E, et al.
Schizophr Bull
. 2024 Dec;
PMID: 39658350
Background: Multiple genetic and environmental risk factors play a role in the development of both schizophrenia-spectrum disorders and affective psychoses. How they act in combination is yet to be clarified....
4.
Austin-Zimmerman I, Spinazzola E, Quattrone D, Wu-Choi B, Trotta G, Li Z, et al.
Psychol Med
. 2024 Dec;
:1-13.
PMID: 39637925
Background: The association between cannabis and psychosis is established, but the role of underlying genetics is unclear. We used data from the EU-GEI case-control study and UK Biobank to examine...
5.
DAndrea G, Quattrone D, Tripoli G, Spinazzola E, Gayer-Anderson C, Jongsma H, et al.
Acta Psychiatr Scand
. 2024 Nov;
151(4):506-520.
PMID: 39483050
Background: Urbanicity is a well-established risk factor for psychosis. Our recent multi-national study found an association between urbanicity and clinical psychosis in Northern Europe but not in Southern Europe. In...
6.
Andreo-Jover J, Fernandez-Jimenez E, Bobes J, Cebria A, Crespo-Facorro B, de la Torre-Luque A, et al.
Psicothema
. 2024 Oct;
36(4):403-413.
PMID: 39466020
Background: Suicide attempt (SA) lethality is associated with heightened suicidal desires and social cognition deficits. Fearlessness about death (FAD) and hypomentalizing may play a role in SA and self-harm. Although...
7.
Alameda L, Rodriguez V, Di Forti M, Spinazzola E, Trotta G, Arango C, et al.
Transl Psychiatry
. 2024 Oct;
14(1):454.
PMID: 39461938
Childhood adversity is associated with various clinical dimensions in psychosis; however, how genetic vulnerability shapes the adversity-associated psychopathological signature is yet to be studied. We studied data of 583 First...
8.
Garcia-Fernandez A, Bobes-Bascaran T, Martinez-Cao C, Gonzalez-Blanco L, Fernandez-Fernandez J, Zurron-Madera P, et al.
Transl Psychiatry
. 2024 Oct;
14(1):438.
PMID: 39414779
Background: Recent evidence indicates that the risk of death by suicide in teenagers has increased significantly worldwide. Consequently, different therapeutic interventions have been proposed for suicidal behavior in this particular...
9.
Dempster E, Wong C, Burrage J, Hannon E, Quattrone D, Trotta G, et al.
Mol Psychiatry
. 2024 Oct;
PMID: 39406996
The rising prevalence and legalisation of cannabis worldwide have underscored the need for a comprehensive understanding of its biological impact, particularly on mental health. Epigenetic mechanisms, specifically DNA methylation, have...
10.
Dal Santo F, Garcia-Portilla M, Fernandez-Egea E, Gonzalez-Blanco L, Saiz P, Giordano G, et al.
Schizophrenia (Heidelb)
. 2024 Sep;
10(1):81.
PMID: 39349504
The Positive and Negative Syndrome Scale (PANSS) is the most widely used rating scale to assess psychotic symptoms in patients with schizophrenia and other primary psychoses. However, a definitive consensus...